16.0 References 
1. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman 
JU. Interferon-alpha produces sustained cytogenetic responses in 
chronic myelogenous leukemia. Ann Int Med 1991; 114:532-538. 
2. Kantarjian HM, Talpaz M, LeMaistre CF, et al. Intensive, 
combination chemotherapy and autologous bone marrow 
transplantation leads to the reappearance of Philadelphia 
chromosome-negative cells in chronic myelogenous leukemia. Cancer 
1991; 67:2959-2965. 
3. Deisseroth A, Kantarjian H, Talpaz M, et al . Integration of 
molecular biology and genetics with biological and 
chemotherapeutic approaches to the rearrangement of chronic 
myelogenous leukemia. In: Dicke K, Armitage JO, Dicke-Evinger MJ, 
eds. Autologous Bone Marrow Transplantation: Proceedings of the 
Fifth International Symposium. Omaha: University of Nebraska 
Medical Center, 1991:229-236. 
4. Hughes TP, Brito-Babapulle F, Tollit DJ, et al. Induction of 
Philadelphia-negative hemopoiesis and prolongation of chronic 
phase in patients with chronic myeloid leukemia treated with high 
dose chemotherapy and transfusion of peripheral blood stem cells. 
In: Dicke K, Armitage JO, Dicke-Evinger MJ, eds. Autologous Bone 
Marrow Transplantation: Proceedings of the Fifth International 
Symposium. Omaha: University of Nebraska Medical Center, 
1991:219-228. 
5. McNiece IK, Stewart FM, Deacon DM, et al. Detection of a 
human CFC with a high proliferative potential. Blood 1989; 
74:609-612. 
6. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW. Survival and 
retrovirus infection of murine hematopoietic stem cells in vitro: 
effects of 5-FU and method of infection. Exp Hematol 1991; 
19:206-212. 
7. Thomas ED, Clift RA. Indications for marrow transplantation 
in chronic myelocytic leukemia. Blood 1989; 73:861-864. 
8. Thomas ED, et al . Marrow transplantation for the treatment 
of chronic myelocytic leukemia. Ann Int Med 1986; 104:155-163. 
9. Gale RP. Risk factors for acute graft-versus-host disease. 
Brit J Haematol 1987; 67:397-406. 
10. Gale RP. Potential utilization of a national HLA-typed donor 
pool for bone marrow transplantation. Transplantation 1986; 
42:229-233. 
Recombinant DNA Research, Volume 16 
[175] 
